Sponsor or institution

Clinical trials and research at Jinling Hospital, China

• 27Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (27)

• Brown fat activity after cold exposure measured by PET/CT in healthy people and those with metabolic conditions

  This study tests how brown adipose tissue responds to cold exposure using PET/CT in adults aged 18-40, including some with diabetes or high cholesterol.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07908719

• Peg IFNα-2b plus targeted immunotherapy for unresectable HBV-related HCC

  This study tests whether adding pegylated interferon alpha-2b to targeted immunotherapy can help patients with unresectable HBV-related liver cancer stay or improve beyond standard nucleoside therapy.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07769827

• Perioperative UDCA to Protect Kidney Function in Partial Nephrectomy

  This study tests whether giving ursodeoxycholic acid around surgery can help protect kidney function in adults having partial nephrectomy for kidney tumors.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT07672860

• CD70-Targeted Imaging-Guided Pause of Therapy in Metastatic Clear Cell RCC

  This study tests whether patients with metastatic clear cell RCC who respond to first-line PD-1/PD-L1 inhibitors plus VEGFR-TKI can safely pause treatment guided by CD70-targeted Immuno-PET/CT imaging.

  Recruiting at 5 sites Phase 2 Jinling Hospital, China · Nanjing, Jiangsu and 4 other locations · NCT07615348

• Gut microbiota modulation to retry immunotherapy in advanced kidney cancer

  This trial tests whether changing gut bacteria can help people with advanced renal cell carcinoma respond again to immunotherapy after resistance.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu and 1 other locations · NCT07611825

• Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer

  This study looks at whether surgery improves survival for people with localized small cell esophageal cancer compared with non-surgical treatment.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07596654

• Perioperative toripalimab plus lenvatinib for multi-stage clear cell kidney cancer

  This trial tests whether giving toripalimab with lenvatinib before surgery helps shrink or kill tumors in people with localized, locally advanced, or metastatic clear cell kidney cancer.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT07571551

• DC-CIK immune cell therapy combined with PD-1/CTLA-4 bispecific antibody and regorafenib for third-line advanced colorectal cancer

  This treatment tries to see if combining a patient's own DC-CIK immune cells with a PD-1/CTLA-4 bispecific antibody plus regorafenib helps people with advanced colorectal cancer who have already received standard therapies.

  Recruiting Early Phase 1 Jinling Hospital, China · Nanjing, Jiangsu · NCT07343791

• Contrast-enhanced ultrasound and super-resolution imaging to predict kidney function after nephrectomy

  This project will test whether special ultrasound scans—contrast-enhanced ultrasound and super-resolution imaging—can help predict kidney function and the risk and recovery of acute kidney injury in adults having partial or radical nephrectomy for kidney cancer.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07294859

• Remote ischemic preconditioning to prevent early worsening after small deep (perforating artery) ischemic stroke

  This trial will test whether brief, repeated arm blood-pressure cuff inflations (remote ischemic preconditioning) can prevent early neurological worsening in adults who have had a small deep perforating artery ischemic stroke within 48 hours.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07237542

• PET/CT-guided treatment break for metastatic kidney cancer with favorable or intermediate IMDC risk

  This trial tries using PET/CT scans to guide temporary treatment breaks for people with metastatic kidney cancer (IMDC favorable or intermediate risk) who have had at least 12 months of combined PD-1/PD-L1 immunotherapy plus a VEGFR TKI and show a metabolic response.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT07175480

• A registry for cardiovascular bio-imaging and multi-omics data

  This study is trying to collect and analyze different types of health data from adults who have had heart imaging to see how genetics and environment affect heart disease and find ways to prevent and manage it.

  Recruiting at 3 sites Jinling Hospital, China · Nanjing, Jiangsu and 2 other locations · NCT06894095

• Using CCTA to Manage Non-Obstructive Coronary Artery Disease

  This study is testing if using a special heart scan called CCTA to manage non-obstructive coronary artery disease can help people control their cholesterol better and lower their risk of serious heart problems compared to regular care.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06843005

• Using a removable titanium clip to treat acute gastric variceal bleeding

  This study is testing a new removable titanium clip to see if it can help stop severe bleeding from stomach varices in patients when other treatments aren't possible.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06736314

• Using a special stent to treat benign duodenal strictures

  This study is testing a special stent to see if it can help people with benign duodenal strictures feel better by keeping the narrowed area open and preventing the stent from moving out of place.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06736301

• Using vorolanib for treating advanced kidney cancer

  This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06676527

• Adebrelimab and chidamide with gemcitabine plus S-1 for advanced pancreatic cancer

  This study will test whether adding the immunotherapy adebrelimab and the oral drug chidamide to standard chemotherapy (gemcitabine plus S-1) helps people with unresectable locally advanced or metastatic pancreatic cancer respond better or live longer.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT06584227

• Neoantigen mRNA vaccines for resectable pancreatic cancer

  This study is testing a new personalized vaccine and a medication for people with resectable pancreatic cancer to see if it helps them do better after surgery and chemotherapy.

  Recruiting Early Phase 1 Jinling Hospital, China · Nanjing, Jiangsu · NCT06326736

• Multimodal radiotherapy for advanced renal cell carcinoma after immunotherapy

  This study is testing whether combining different types of radiation therapy with ongoing treatment can help people with advanced kidney cancer who haven't responded well to previous immunotherapy.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT06255223

• Blinded randomized test of an AI tool to find brain aneurysms on head CTA

  This trial will test whether an AI tool that helps read head CT angiograms can improve detection of brain aneurysms in adults having CTA scans.

  Recruiting at 21 sites Jinling Hospital, China · Hefei, Anhui and 20 other locations · NCT06118840

• Combination treatment for HER2-positive upper tract urothelial carcinoma after surgery

  This study is testing a new combination of targeted therapy and immune treatment to see if it helps prevent cancer from coming back in patients with HER2-positive upper tract urothelial carcinoma after surgery.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT05917158

• Monitoring kidney cancer using blood tests for DNA changes

  This study is testing if blood tests that look for DNA changes can help track kidney cancer in patients before and after surgery.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05917106

• Comparing radial and femoral access for treating acute basilar artery occlusion

  This study is testing whether using a wrist (radial) access instead of a groin (femoral) access for treating a specific type of stroke can lead to better results for patients.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05903560

• Using coronary CTA to improve heart disease prevention in asymptomatic Chinese adults

  This study is testing if using a special heart scan can help prevent heart disease better than regular risk assessments in healthy adults aged 40 to 69 in Nanjing.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05725096

• Comparing two surgical methods for Crohn's disease treatment

  This study is testing which of two surgical methods works better for treating Crohn's disease in patients needing bowel surgery to see which one leads to fewer problems after the operation.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05658081

• Using biologics to treat stricturing Crohn's disease

  This study is testing whether biologic treatments can help people with stricturing Crohn's disease who don't need surgery.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05645055

• Comparing surgery and biologics for treating stricturing Crohn's disease

  This study is testing whether surgery or biologic treatments work better for people with stricturing Crohn's disease who haven't found relief with regular medications.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT05421455

Quick answers

How many clinical trials run by Jinling Hospital, China are recruiting right now?

27, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 8, Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →